Nothing Special   »   [go: up one dir, main page]

BR112022004099A2 - Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx - Google Patents

Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx

Info

Publication number
BR112022004099A2
BR112022004099A2 BR112022004099A BR112022004099A BR112022004099A2 BR 112022004099 A2 BR112022004099 A2 BR 112022004099A2 BR 112022004099 A BR112022004099 A BR 112022004099A BR 112022004099 A BR112022004099 A BR 112022004099A BR 112022004099 A2 BR112022004099 A2 BR 112022004099A2
Authority
BR
Brazil
Prior art keywords
compound
atx
treating
pharmaceutical composition
related disease
Prior art date
Application number
BR112022004099A
Other languages
English (en)
Inventor
Hongna Sun
Jie Shen
Lie Li
Qiangqiang Fu
Sijun Lei
Wenjun Wei
Xiaohua Ding
Xuejun Zhang
Yang Zang
Original Assignee
Wuhan Humanwell Innovative Drug Res And Development Center Limited Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Humanwell Innovative Drug Res And Development Center Limited Company filed Critical Wuhan Humanwell Innovative Drug Res And Development Center Limited Company
Publication of BR112022004099A2 publication Critical patent/BR112022004099A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx. um composto de pirimidina, relacionado mais especificamente a um composto de pirimidina, e um método de preparação para o mesmo, e um uso do mesmo na preparação de um fármaco. é provido um composto representado pela fórmula (i), ou um tautômero, estereoisômero, hidrato, solvato, sal ou pró-fármaco farmaceuticamente aceitável do composto representado pela fórmula (i). o composto descrito tem um efeito inibitório óbvio sobre uma enzima atx, exibe excelente estabilidade do metabolismo hepático, é metabolizado mais lentamente no corpo humano e tem maior exposição.
BR112022004099A 2019-09-06 2020-09-04 Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx BR112022004099A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910846545 2019-09-06
CN201910841159 2019-09-06
PCT/CN2020/113474 WO2021043260A1 (zh) 2019-09-06 2020-09-04 嘧啶类化合物及其制备方法

Publications (1)

Publication Number Publication Date
BR112022004099A2 true BR112022004099A2 (pt) 2022-05-31

Family

ID=74833850

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004099A BR112022004099A2 (pt) 2019-09-06 2020-09-04 Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx

Country Status (10)

Country Link
US (1) US20220204479A1 (pt)
EP (1) EP4029858A4 (pt)
JP (1) JP7389238B2 (pt)
KR (1) KR20220058614A (pt)
CN (1) CN112457296B (pt)
AU (1) AU2020342202B2 (pt)
BR (1) BR112022004099A2 (pt)
CA (1) CA3149062A1 (pt)
IL (1) IL291114A (pt)
WO (1) WO2021043260A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113943276A (zh) * 2020-07-16 2022-01-18 武汉人福创新药物研发中心有限公司 氮杂环类化合物及其用途
KR20230049673A (ko) * 2020-09-25 2023-04-13 상하이 메이유에 바이오테크 디벨롭먼트 컴퍼니 리미티드 피리미딘 카르복스아미드 화합물 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051296B2 (en) * 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
JP2012072067A (ja) * 2010-09-28 2012-04-12 Astellas Pharma Inc 含窒素芳香族へテロ環化合物
CN103958481B (zh) * 2011-10-28 2017-06-30 因西必泰克新有限公司 可用于治疗的哒嗪衍生物
TWI499591B (zh) 2013-01-11 2015-09-11 Lilly Co Eli 雙環嘧啶化合物
PL2970255T3 (pl) * 2013-03-14 2017-10-31 Galapagos Nv Związki i ich kompozycje farmaceutyczne do leczenia zaburzeń zapalnych
WO2014202458A1 (en) 2013-06-19 2014-12-24 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
DK3122750T3 (da) * 2014-03-26 2019-11-04 Hoffmann La Roche Bicykliske forbindelser som autotaxin (ATX)- og lysofosfatidsyre (LPA)-produktionshæmmere
CN104926792B (zh) * 2015-07-08 2018-10-02 厦门稀土材料研究所 甲硝唑衍生物及其制备方法和用途
JP7228702B2 (ja) * 2019-02-01 2023-02-24 武漢人福創新薬物研発中心有限公司 化合物、薬物組成物、および治療薬
CN113943276A (zh) * 2020-07-16 2022-01-18 武汉人福创新药物研发中心有限公司 氮杂环类化合物及其用途
CN113943275A (zh) * 2020-07-16 2022-01-18 武汉人福创新药物研发中心有限公司 嘧啶类化合物及其用途

Also Published As

Publication number Publication date
IL291114A (en) 2022-05-01
KR20220058614A (ko) 2022-05-09
AU2020342202B2 (en) 2023-07-06
US20220204479A1 (en) 2022-06-30
WO2021043260A1 (zh) 2021-03-11
CN112457296B (zh) 2023-11-07
EP4029858A4 (en) 2023-11-01
AU2020342202A1 (en) 2022-04-14
CN112457296A (zh) 2021-03-09
JP2022551393A (ja) 2022-12-09
EP4029858A1 (en) 2022-07-20
JP7389238B2 (ja) 2023-11-29
CA3149062A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
BR112015012693A2 (pt) derivados de pirimidona e seu uso no tratamento, melhora ou prevenção de uma doença viral
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
BR112015020302A2 (pt) derivado de pirazol
BR112019003504A2 (pt) compostos de amino-pirrolopirimidinona e métodos de uso dos mesmos
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
BRPI0511967B8 (pt) derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina, seu uso e composição farmacêutica que os compreende
AR062394A1 (es) Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis
BR112018004175B8 (pt) Composto pirazolo[3,4-d]pirimidina, composição farmacêutica e usos terapêuticos do dito composto
GT200800256A (es) Derivados de pirazolo [3,4-d]-pirimidina útiles para tratar trastornos respiratorios
UY39027A (es) Uso de favipiravir en el tratamiento de la infección por coronavirus
BR112013017302A2 (pt) formulações de imunossupressor
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
BR112016028876A2 (pt) composto, composição farmacêutica, método para tratar uma doença ou condição em um ser humano, kit, e, uso de um composto, um sal, isômero ou uma mistura farmaceuticamente aceitável dos mesmos.
BRPI0706992C8 (pt) composto de fórmula (i) e formulação farmacêutica
BR112012013252A2 (pt) composição farmacêutica tópica, preservativo, composto, e, uso do mesmo
AR062401A1 (es) Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
BR112014001369A2 (pt) derivados de ácido hidroxâmico de heteroarila e uso dos mesmos no tratamento, melhora ou prevenção de doença viral
BR112022001568A2 (pt) Composto, método para preparação do composto, composição farmacêutica, e, uso do composto
BR112022004099A2 (pt) Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
BR112019002513A2 (pt) uso e dosagem de agentes terapêuticos para endometriose
AR064543A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
BR112017021583A2 (pt) métodos para o tratamento de transtornos inflamatórios
BR112023022649A2 (pt) Uso de 5-nitro-8-hidroxiquinolina

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]